Your browser doesn't support javascript.
loading
Economic burden of female genital mutilation in 27 high-prevalence countries.
Tordrup, David; Bishop, Chrissy; Green, Nathan; Petzold, Max; Vallejo, Fernando Ruiz; Vogel, Joshua P; Pallitto, Christina.
Afiliação
  • Tordrup D; WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht, The Netherlands.
  • Bishop C; Triangulate Health Ltd, Doncaster, UK.
  • Green N; Independent Consultant, London, UK.
  • Petzold M; University College London, London, UK.
  • Vallejo FR; School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Vogel JP; Institute of Public Health, Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Pallitto C; Maternal, Child and Adolescent Health Program, Burnet Institute, Melbourne, Victoria, Australia.
BMJ Glob Health ; 7(2)2022 02.
Article em En | MEDLINE | ID: mdl-35105556
BACKGROUND: Female genital mutilation (FGM) is a traditional harmful practice affecting 200 million women and girls globally. Health complications of FGM occur immediately and over time, and are associated with healthcare costs that are poorly understood. Quantifying the global FGM-related burden is essential for supporting programmes and policies for prevention and mitigation. METHODS: Health complications of FGM are derived from a meta-analysis and stratified by acute, uro-gynaecological, obstetric and psychological/sexual. Treatment costs are calculated from national cohort models of 27 high-burden countries over 30 years. Savings associated with full/partial abandonment are compared with a current incidence reference scenario, assuming no changes in FGM practices. RESULTS: Our model projects an increasing burden of FGM due to population growth. As a reference scenario assuming no change in practices, prevalent cases in 27 countries will rise from 119.4 million (2018) to 205.8 million (2047). Full abandonment could reduce this to 80.0 million (2047), while partial abandonment is insufficient to reduce cases. Current incidence economic burden is US$1.4 billion/year, rising to US$2.1 billion/year in 2047. Full abandonment would reduce the future burden to US$0.8 billion/year by 2047. CONCLUSION: FGM is a human rights violation, a public health issue and a substantial economic burden that can be avoided through effective prevention strategies. While decreasing trends are observed in some countries, these trends are variable and not consistently observed across settings. Additional resources are needed to prevent FGM to avoid human suffering and growing costs. The findings of this study warrant increased political commitment and investment in the abandonment of FGM.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Circuncisão Feminina Tipo de estudo: Health_economic_evaluation / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male / Pregnancy Idioma: En Revista: BMJ Glob Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Circuncisão Feminina Tipo de estudo: Health_economic_evaluation / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male / Pregnancy Idioma: En Revista: BMJ Glob Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido